000 | 01711 a2200517 4500 | ||
---|---|---|---|
005 | 20250513161316.0 | ||
264 | 0 | _c19990514 | |
008 | 199905s 0 0 eng d | ||
022 | _a0017-5749 | ||
024 | 7 |
_a10.1136/gut.44.2.212 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWarny, M | |
245 | 0 | 0 |
_aBovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine. _h[electronic resource] |
260 |
_bGut _cFeb 1999 |
||
300 |
_a212-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Bacterial _xmetabolism |
650 | 0 | 4 |
_aAntitoxins _xmetabolism |
650 | 0 | 4 |
_aBacterial Toxins _ximmunology |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aClostridioides difficile _ximmunology |
650 | 0 | 4 |
_aColostrum _ximmunology |
650 | 0 | 4 |
_aDigestive System _xmetabolism |
650 | 0 | 4 |
_aEnterotoxins _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastric Mucosa _xmetabolism |
650 | 0 | 4 | _aGastrointestinal Transit |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIleum _xmetabolism |
650 | 0 | 4 |
_aImmunoglobulin G _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
700 | 1 | _aFatimi, A | |
700 | 1 | _aBostwick, E F | |
700 | 1 | _aLaine, D C | |
700 | 1 | _aLebel, F | |
700 | 1 | _aLaMont, J T | |
700 | 1 | _aPothoulakis, C | |
700 | 1 | _aKelly, C P | |
773 | 0 |
_tGut _gvol. 44 _gno. 2 _gp. 212-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.44.2.212 _zAvailable from publisher's website |
999 |
_c9857123 _d9857123 |